Wilbanks Smith & Thomas Asset Management’s Strata Critical Medical Inc SRTA Stock Holding History
Bought
Maintained
Sold
Other funds holding SRTA
AIM
HVCM
NAMA
EMG
AWS
Wilbanks Smith & Thomas Asset Management's SRTA Position: Q1 2022 in Review
Wilbanks Smith & Thomas Asset Management sold out of Strata Critical Medical Inc (SRTA) in Q1 2022, closing a stake of 10,222 shares — an estimated $90K sold.
Wilbanks Smith & Thomas Asset Management first reported a position in SRTA in Q3 2021 and held it in 2 quarters. The position peaked at $106K in Q3 2021. 78 funds tracked by Wall St. Rank hold SRTA as of Q1 2022.
- Wilbanks Smith & Thomas Asset Management reported no remaining Strata Critical Medical Inc position as of Q1 2022 after selling out during the quarter.
- Wilbanks Smith & Thomas Asset Management sold 10,222 Strata Critical Medical Inc shares in Q1 2022, an estimated $90K.
- Wilbanks Smith & Thomas Asset Management first reported a position in Strata Critical Medical Inc in Q3 2021 and held it in 2 quarters.
- Wilbanks Smith & Thomas Asset Management's Strata Critical Medical Inc position peaked at $106K in Q3 2021.
- 78 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2022.
Based on Wilbanks Smith & Thomas Asset Management's 13F filing for Q1 2022, filed 5 May 2022.